Sign In
NewsRadar

Catalan medical diagnostics company STAT-Diagnostica gets €17 million

6 May 2013 17:17
By Tornado Staff

STAT-Diagnostica has closed a Series B financing round of €17 million led by new investor Kurma Life Sciences Partners. Other new investors in the round were Idinvest, Boehringer Ingelheim Venture Fund and Caixa Capital Risc. Existing shareholders Ysios Capital and Axis also participated in this latest round. The proceeds will be used to complete development of the company’s near patient testing (NPT) diagnostic system and clinical validation of its first products. Grant Thornton acted as financial advisor for the new investors and Cuatrecasas as legal advisor. Rousaud Costas Duran acted as legal advisor for the company.

Founded in 2010 in Barcelona, STAT-Diagnostica is focused on the development of NPT solutions for fast and accurate diagnosis of certain medical conditions. Its in-vitro diagnostic system consolidates molecular and immunoassay techniques in a single device and offers multi-analyte and multi-sample capabilities and also provides results in less than 30 minutes. The first clinical applications will be directed at infectious disease detection, antibiotic resistance determination and detection of biomarkers in critically ill patients.



Related stories
Mucosis wins Wellcome Trust award and backing from current investors
Massive £50 million Series B round for UK-based Cell Medica
€6.3 million Series C for Humedics’ liver function diagnostic device
Medication safety system provider Mint Solutions secures €4.4 million
Big VC rounds for Ganymed and MISSION to fight cancer


Up
Data


24,275
Tech investments
From our Online Data Service
15,691
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
May 18N/ABusiness applications
May 18€1.3MKnowledge management
May 18€9.1MInternet services
May 18€18.0MContent management
May 18€0.4MOther Computers & Electronics
May 17€51.0MeLearning
May 17€0.4MInternet services

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises €37.5 million in series a





About usContact usLegal Information
Copyright © 1999-2018
Emerging Technology Research Europe Inc. All rights reserved.